Ryan Specialty [RYAN] vs Fidelity National [FNF] Detailed Stock Comparison
Ryan Specialty
NYSE
Loading...
Fidelity National
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Ryan Specialty wins in 5 metrics, Fidelity National wins in 14 metrics, with 0 ties. Fidelity National appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ryan Specialty | Fidelity National | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 147.55 | 15.13 | Fidelity National |
| Price-to-Book Ratio | 12.30 | 2.05 | Fidelity National |
| Debt-to-Equity Ratio | 309.01 | 54.14 | Fidelity National |
| PEG Ratio | 18.69 | -1.55 | Fidelity National |
| EV/EBITDA | 15.05 | 7.03 | Fidelity National |
| Profit Margin (TTM) | 2.02% | 7.90% | Fidelity National |
| Operating Margin (TTM) | 23.84% | 12.01% | Ryan Specialty |
| EBITDA Margin (TTM) | 23.84% | 12.01% | Ryan Specialty |
| Return on Equity | 16.98% | 13.75% | Ryan Specialty |
| Return on Assets (TTM) | 3.48% | 1.15% | Ryan Specialty |
| Free Cash Flow (TTM) | $467.87M | $6.67B | Fidelity National |
| Dividend Yield | 0.51% | 2.73% | Fidelity National |
| 1-Year Return | -7.73% | 1.28% | Fidelity National |
| Price-to-Sales Ratio (TTM) | 5.66 | 1.19 | Fidelity National |
| Enterprise Value | $11.60B | $17.51B | Fidelity National |
| EV/Revenue Ratio | 4.21 | 1.29 | Fidelity National |
| Revenue per Share (TTM) | $22 | $50 | Fidelity National |
| Earnings per Share (Diluted) | $0.40 | $3.93 | Fidelity National |
| Beta (Stock Volatility) | 0.64 | 1.06 | Ryan Specialty |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Ryan Specialty vs Fidelity National Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ryan Specialty | 0.93% | -0.59% | -9.30% | -15.83% | -14.66% | -5.48% |
| Fidelity National | -0.34% | -0.83% | 8.52% | 2.52% | 1.81% | 6.23% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ryan Specialty | -7.73% | 36.41% | 107.07% | 107.07% | 107.07% | 107.07% |
| Fidelity National | 1.28% | 53.59% | 84.92% | 132.30% | 608.82% | 300.74% |
Performance & Financial Health Analysis: Ryan Specialty vs Fidelity National
| Metric | RYAN | FNF |
|---|---|---|
| Market Information | ||
| Market Cap | $15.58B | $16.16B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,335,130 | 1,430,720 |
| 90 Day Avg. Volume | 1,361,953 | 2,101,313 |
| Last Close | $59.75 | $59.27 |
| 52 Week Range | $55.77 - $77.16 | $50.61 - $66.72 |
| % from 52W High | -22.56% | -11.17% |
| All-Time High | $77.16 (Mar 31, 2025) | $66.72 (Mar 31, 2025) |
| % from All-Time High | -22.56% | -11.17% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.24% | 0.15% |
| Quarterly Earnings Growth | 0.11% | -0.09% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.08% |
| Operating Margin (TTM) | 0.24% | 0.12% |
| Return on Equity (TTM) | 0.17% | 0.14% |
| Debt to Equity (MRQ) | 309.01 | 54.14 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $4.80 | $29.07 |
| Cash per Share (MRQ) | $1.40 | $15.95 |
| Operating Cash Flow (TTM) | $571.34M | $6.87B |
| Levered Free Cash Flow (TTM) | $429.36M | $1.59B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.51% | 2.73% |
| Last 12-Month Dividend | $0.34 | $1.48 |
Valuation & Enterprise Metrics Analysis: Ryan Specialty vs Fidelity National
| Metric | RYAN | FNF |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 147.55 | 15.13 |
| Forward P/E | 26.71 | 9.61 |
| PEG Ratio | 18.69 | -1.55 |
| Price to Sales (TTM) | 5.66 | 1.19 |
| Price to Book (MRQ) | 12.30 | 2.05 |
| Market Capitalization | ||
| Market Capitalization | $15.58B | $16.16B |
| Enterprise Value | $11.60B | $17.51B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.21 | 1.29 |
| Enterprise to EBITDA | 15.05 | 7.03 |
| Risk & Other Metrics | ||
| Beta | 0.64 | 1.06 |
| Book Value per Share (MRQ) | $4.80 | $29.07 |
Financial Statements Comparison: Ryan Specialty vs Fidelity National
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | RYAN | FNF |
|---|---|---|
| Revenue/Sales | $690.17M | $3.58B |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | $51.04M | $382.00M |
| Income Tax | $55.43M | $98.00M |
| Net Income (Profit) | $-4.39M | $293.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | RYAN | FNF |
|---|---|---|
| Cash & Equivalents | $203.55M | $4.33B |
| Total Current Assets | N/A | N/A |
| Total Current Liabilities | N/A | N/A |
| Long-Term Debt | $3.81B | $4.77B |
| Total Shareholders Equity | $1.06B | $8.80B |
| Retained Earnings | $79.34M | $5.93B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | RYAN | FNF |
|---|---|---|
| Operating Cash Flow | $-197.82M | $150.00M |
| Capital Expenditures | N/A | $-37.00M |
| Free Cash Flow | $-159.56M | $1.08B |
| Debt Repayment | $-154.25M | $-300.00M |
| Common Stock Repurchase | N/A | $-24.00M |
Short Interest & Institutional Ownership Analysis
| Metric | RYAN | FNF |
|---|---|---|
| Shares Short | 4.93M | 3.96M |
| Short Ratio | 4.28 | 3.37 |
| Short % of Float | 0.04% | 0.02% |
| Average Daily Volume (10 Day) | 1,335,130 | 1,430,720 |
| Average Daily Volume (90 Day) | 1,361,953 | 2,101,313 |
| Shares Outstanding | 125.41M | 275.00M |
| Float Shares | 108.25M | 256.84M |
| % Held by Insiders | 0.14% | 0.06% |
| % Held by Institutions | 0.90% | 0.82% |
Dividend Analysis & Yield Comparison: Ryan Specialty vs Fidelity National
| Metric | RYAN | FNF |
|---|---|---|
| Last 12-Month Dividend | $0.34 | $1.48 |
| Last 12-Month Dividend Yield | 0.51% | 2.73% |
| 3-Year Avg Annual Dividend | $0.19 | $1.71 |
| 3-Year Avg Dividend Yield | 0.18% | 1.04% |
| 3-Year Total Dividends | $0.56 | $5.14 |
| Ex-Dividend Date | Mar 04, 2025 | Mar 17, 2025 |